SG Americas Securities
ANTH

SG Americas Securities’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

SG Americas Securities’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-28,892
Closed -$98K – 3709
2017
Q1 		$98K Buy
28,892
+26,511
+1,113% +$125K ﹤0.01% 3002
2016
Q4 		$12K Buy
+2,381
New +$41.2K ﹤0.01% 3015
2015
Q4 		– Sell
-2,730
Closed -$133K – 3139
2015
Q3 		$133K Buy
+2,730
New +$191K ﹤0.01% 1694

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

SG Americas Securities's ANTH Position: Q2 2017 in Review

SG Americas Securities sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 28,892 shares — an estimated $98K sold.

SG Americas Securities first reported a position in ANTH in Q3 2015 and held it in 3 quarters. The position peaked at $133K in Q3 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

  • SG Americas Securities reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • SG Americas Securities sold 28,892 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $98K.
  • SG Americas Securities first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • SG Americas Securities's Anthera Pharmaceuticals, Inc. position peaked at $133K in Q3 2015.
  • 40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on SG Americas Securities's 13F filing for Q2 2017, filed 3 Aug 2017.